← Back to all trials
Active Not Recruiting
NCT05689138
Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer
Conditions: Pancreatic Cancer
Sex: All
Healthy volunteers: 1
Enrollment: 100
Sponsor: Peking Union Medical College Hospital
Location: China
Summary
Pancreatic cancer (PCA) is a leading death-related cancer.
There is an urgent need for accurate, noninvasive diagnostic options in the early detection of pancreatic cancer (PCA), since delayed diagnosis increases the risk of metastasis and recurrence.
In this study, by analyzing gut and fecal microbial data among the pancreatic versus healthy populations, we aim to establish an early detection tool to improve PCA detection, and to explore potential diagnostic biomarkers.
Eligibility Criteria
Inclusion Criteria:PCA Newly diagnosed pancreatic cancer patients; No symptoms of jaundice; Did not yet receive any treatmentNC Individuals who were undergoing routine screenings or physical examinationExclusion Criteria:
Source: ClinicalTrials.gov (NCT05689138). StuddyBuddy aggregates publicly available trial information.
